Back to Journals » ClinicoEconomics and Outcomes Research » Volume 7

Cost-effectiveness of ranibizumab versus aflibercept in the treatment of visual impairment due to diabetic macular edema: a UK healthcare perspective

Total article views   Abstract views HTML views PDF downloads Totals
10,397 Dovepress* 7,805 1,147+ 1,235 8,952
PubMed Central* 0 1,445 691 1,445
Totals 7,805 2,592 1,926 10,397
*Since 6 May 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
22 1 0 0 9 12

View citations on PubMed Central and Google Scholar